It is possible that early in prostate cancer, or upon recurrence, androgen signaling triggers PKR activation and subsequent eIF2α-P, leading to anti-proliferative effects, apoptosis, and the activation of tumor suppressor mechanisms. The gene discussed is EIF2AK2; the disease is Familial prostate cancer.